USA TODAY's experts say securing a COVID-19 vaccine in record time could be easy, but distributing it won't be

  • 📰 USATODAY
  • ⏱ Reading Time:
  • 74 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

Once we have a COVID-19 vaccine approved, how will it be distributed? That's the hard part, experts say.

each saw the clock advance an hour. There were no major setbacks, and plans began to fall into place for distributing aanother hour closer to a broadly available vaccine. Some said we're still in the very early morning hours. Others said we're closing in on the goal.

"For the two or three lead candidates, we may have a few million stockpiled doses and a clear production plan for the first couple of hundred million doses," said Prashant Yadav, a medical supply chain expert and senior fellow at the Center for Global Development. Two of the leaders, Pfizer and Moderna, use messenger RNA platforms never before used for an approved vaccine, noted Duke University Law School professor and health law expert Arti Rai.

Waning public interest after a first COVID-19 vaccine is approved could mean that"some of these vaccine trials trailing behind will have to close," saidMonica Gandhi, a professor of medicine and infectious disease expert at the University of California-San Francisco.vaccines across the finish line will be crucial for ensuring everyone, regardless of age, ethnicity, health status and other variables, has a safe and effective vaccine available, said Dr.

AstraZeneca’s trial was paused in September after a British volunteer had a rare neurological complication. Although the trial in the U.K. was allowed to resume, the FDA continued the hold on the U.S. trial. , director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia., president and co-founder of the Center for Medicine in the Public Interest, and a former FDA Associate Commissioner for External Relations.Sandra Crouse Quinn,

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Vaxart, vaccine in pill, room temperature.

They will have a plan. 💔🇺🇸♥️💙BidenHarris2020ToSaveAmerica

I have an idea.

By mail... just like the ballots and hopefully the Dems will harvest the whole lot!!!!

According to the estable look directly to the eclipse genius, the military will do it easily

A vaccine for a virus with a 99.9% recovery rate. No thanks.

During the last debates our dear golfball said 'We have OperationWarpSpeed, the military is going to distribute the vaccine' . . . sounds suspicious AF

Then we have to figure out how we’re going to lose all the weight! — Welcome to the Covid-15 Club!

You don't need to worry folks. The president told me Covid will soon 'miraculously disappear.' No problemo! :-)

Nobody is taking that shit

In India, Political Parties included Free Covid Vaccine if they come to Power after next State Election in their election manifesto. Even the vaccine has not yet find, but all are eagerly waiting for the invention of medicine.

Journalist go last

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 100. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Coronavirus Today: 'COVID, COVID, pandemic, COVID'Of all the issues facing the president, COVID-19 is the one he seems most determined to avoid, according to our Washington bureau chief, David Lauter. “COVID-19 has been likened to an X-ray, revealing fractures in the fragile skeleton of the societies we have built” ---Antonio Guterres
Source: latimes - 🏆 11. / 82 Read more »

Many Californians, particularly Black residents, would skip taking COVID-19 vaccine today, survey findsMost of those surveyed would definitely or probably get a COVID-19 vaccine. But that was true of only 29% of Black respondents That’ll change if Biden wins. Guaranteed. If you are smart you'd skip taking the vaccinne. Absolutely skip
Source: latimes - 🏆 11. / 82 Read more »

Volunteer for a Local Clinical Study | COVID-19 Prevention NetworkDiverse participants are needed in ClinicalTrials for a COVID19 vaccine. Interested in volunteering? Head to NIH’s COVID-19 Prevention Network (COVPN) to learn more: NIH No, no way. I won't participate in any default pharma trials SecAzar NIH trustyou?
Source: HHSGov - 🏆 147. / 63 Read more »

Coronavirus Disease 2019 (COVID-19)Is your mask covering your smile 😷? Here’s an easy way to let someone know they’ve brightened your day using American Sign Language. Learn more about masks from the CDCgov: fema CDCgov Public healthcare is a case for business to make; at the very least access to primary and preventive care. Fewer employees would take sick days, because they wouldn't be infected by walking super spreaders of flu or like. Masses would be able to work and not need gov't assistance CDCgov :) We love this! Great way to incorporate ASL into our lives. CDCgov 👍
Source: HHSGov - 🏆 147. / 63 Read more »

U.S. faces half a million COVID-19 deaths by end-February, study findsMore than a half million people in the United States could die from COVID-19 by the end of February next year, but around 130,000 of those lives could be saved if everybody were to wear masks, according to estimates from a modelling study. ...but her email Could Trump out pass this if this were a real war 😕 Unfortunately, it's to be expected. '“My people bend their tongues like bows to shoot out lies. They REFUSE to stand up for the truth. They only go from bad to worse. They DO NOT know me,” says the Lord.' Jeremiah 9:3
Source: Reuters - 🏆 2. / 97 Read more »

Melania Trump Will Resurface To Throw Halloween Party At White House Despite Covid-19I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com Hasn't the last 4 years been enough of a horror show?
Source: Forbes - 🏆 394. / 53 Read more »